RMT-Epigenomex, Inc.
Reducing Time & Cost for Drug Discovery




CH3 BioSystems is a supplier of high-performance molecular tools and services for the discovery of protein methylation pathways in cells and tissues.  

CH3 BioSystems


CH3 BioSystems is a supplier of high-performance molecular tools and services for the discovery of protein methylation pathways in cells and tissues.  The methylarginine-specific antibody, Anti-mRG (USPTO #6699673), is specifically designed to detect the greatest number of methyl-proteins and peptides currently known.  The immunizing antigen is based on a site of methylation found in a minimally required peptide sequence of consensus for arginine methylation.  Anti-mRG and the many supporting products including enzymes, peptides and cell lines from CH3 BioSystems provide a complete cellular and molecular toolkit for protein methylation research and development.


Additional products now available for sale from CH3's catalog and others in development are designed to promote simple and rapid advances in the biomedical analysis of protein methylation.


Go to: www.ch3biosystems.com for additional information